Pharma

Your Article Summary

See Latest Articles

Cephalons New Product Launches Pace Record 2008 Sales
Cephalon, 02/13/09

Cephalon, Inc. reported 2008 sales of $1.943 billion, compared to sales of $1.727 billion for 2007, exceeding the company's previously issued guidance. Basic income per common share for the full year 2008 was $3.27. Excluding amortization expense and certain other items, basic adjusted income per common share for the full year was $5.39, compared to $4.60 for 2007 and exceeds the high end of the company's earnings guidance range of $5.20 to $5.30.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientifics Heart Failure Devices Based on Landmark MADIT-CRT Trial
Boston Scientific, 03/19/10

Lubricious coatings from Bayer MaterialScience
BayNews International, 03/19/10

Bayer MaterialScience develops drug-releasing coatings for medical applications
BayNews International, 03/19/10

 See all of Medical Devices/Products